Discover tailored educational content for your region—select your country to get started
Global leaders in medical cannabis
Specialising in research, development, production and distribution of medical cannabis. Curaleaf International is dedicated to advancing access to cannabis-based medicines through innovative, reliable, evidence-based information.
Discover more about the active compounds within cannabis and the growing body of evidence
Neurological disorders
Gastrointestinal disorders
Crohn’s Disease
Ulcerative Colitis
Irritable Bowel Syndrome (IBS)
Cancer related disorders
Anxiety
Nausea and Vomiting
Appetite Loss
Depression
Palliative Care
Are you a healthcare professional?
Access our exclusive contents
Articles and Research
Cannabis Use in Attention-Deficit Hyperactivity Disorder (ADHD)
Attention-Deficit Hyperactivity Disorder – commonly referred to by the abbreviation “ADHD” – is a neurodevelopmental…
Outcomes for Generalised Anxiety Disorder from the UK Medical Cannabis Registry
Since 2019, the UK Medical Cannabis Registry has collected real-world evidence from patients prescribed medical…